Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

New diabetes guidance ups prevention game

Identifying people who are at risk for Type 2 diabetes should become “a focus for everybody,” say new UK guidelines.

13 Jul 2012

NICE: GPs must target diabetes prevention

Guidance for the prevention of type 2 diabetes out today from NICE urges GPs to step up efforts to get high-risk patients onto lifestyle intervention programmes. As trailed at the end of last year, the guidance recommends that GPs run checks on their practice register using a validated computerised diabetes risk tool and invite those falling into high-risk groups for a proper risk assessment, in line with the NHS Health Check programme.

12 Jul 2012

Overweight, obesity prevalent in psychiatric inpatients

Most inpatients with psychiatric disorders are overweight or obese, say Australian researchers who urge closer monitoring of the physical health of patients with mental illnesses.

12 Jul 2012

Nutrisystem announces debut of enhanced weight management plan for people with diabetes

Nutrisystem, a leading provider of weight management products and services, today announced the debut of its enhanced weight management plan for people with diabetes, Nutrisystem D.

12 Jul 2012

Arrowhead initiates Adipotide Phase 1 trial in obesity

Arrowhead Research Corporation, a targeted therapeutics company, today announced that the first patient has been dosed in a Phase 1 clinical trial with Adipotide, a new class of treatment for obesity.

11 Jul 2012

Registration now open for Disease Models & Mechanisms' one-day symposium

Registration is now open for Disease Models & Mechanisms' one-day symposium entitled Protein-Folding Diseases: Models & Mechanisms.

11 Jul 2012

LUHS opens multidisciplinary center to treat obesity

Loyola University Health System (LUHS) will open a multidisciplinary center to treat obesity today, Tuesday, July 10. The new Loyola Center for Metabolic Surgery & Bariatric Care is located at 719 W. North Ave.in Melrose Park.

11 Jul 2012

Book explains complex world of personalized medicine

Personalized medicine has promised to radically change the way we look at health and disease. Talk of tailored drug therapies and early detection of cancer has captured the attention of scientists and lay people alike. So when will patients start to reap the benefits of this medical revolution?

11 Jul 2012

Connections between daily stressors of police work and obesity, suicide

The daily psychological stresses that police officers experience in their work put them at significantly higher risk than the general population for a host of long-term physical and mental health effects. That's the overall finding of a major scientific study of the Buffalo Police Department called Buffalo Cardio-Metabolic Occupational Police Stress (BCOPS) conducted over five years by a University at Buffalo researcher.

11 Jul 2012

Caffeine combats skin cancer risk

Drinking three or more cups of caffeinated coffee a day can significantly reduce a person’s risk for basal cell carcinoma, show study findings.

10 Jul 2012

Two-drug combo increases diabetes patients’ goal achievement

Post-hoc analysis of randomized trial results shows that treating individuals with Type 2 diabetes with a combination of phentermine and topiramate increases their achievement of goals recommended for the management of their condition.

10 Jul 2012

Diabetes drug raises bladder cancer risk

Data from a robust meta-analysis have reinforced concerns about the link between the Type 2 diabetes drug, pioglitazone, and bladder cancer.

10 Jul 2012

New devices effectively monitor and control blood sugar levels in people with diabetes

Newer technologies designed to help people with type 1 diabetes monitor their blood sugar levels daily work better than traditional methods and require fewer painful needle sticks, new Johns Hopkins research suggests.

10 Jul 2012

New blood sugar monitor works better than conventional methods

10 Jul 2012

Glycemic index varies from one type of rice to another

Research analysing 235 types of rice from around the world has found its glycemic index (GI) varies from one type of rice to another with most varieties scoring a low to medium GI. This finding is good news because it not only means rice can be part of a healthy diet for the average consumer, it also means people with diabetes, or at risk of diabetes, can select the right rice to help maintain a healthy, low GI diet.

10 Jul 2012

Adiponectin reduces depression-like symptoms in mice

A hormone with anti-diabetic properties also reduces depression-like symptoms in mice, researchers from the School of Medicine at the UT Health Science Center San Antonio reported today.

10 Jul 2012

Viewpoints: Daschle says health law still has 4 hurdles; Commentators from states such as Calif., Texas and Florida wrestle with options

The GOP-controlled U.S. House plans to hold what can only be called symbolic votes on repealing the sweeping reforms they deride as "Obamacare." Meanwhile, at least 15 governors are said to be leaning toward refusing to expand state Medicaid programs -- a key part of the reform's strategy to provide some form of health insurance to the 32 million people now going without coverage.

10 Jul 2012

Pioglitazone may raise bladder cancer risk

Study evidence supports a link between thiazolidinedione use, particularly pioglitazone, and bladder cancer in patients with Type 2 diabetes, Canadian researchers report.

9 Jul 2012

Pioglitazone may raise bladder cancer risk

Study evidence supports a link between thiazolidinedione use, particularly pioglitazone, and bladder cancer in patients with Type 2 diabetes, Canadian researchers report.

9 Jul 2012

Ampio announces results from Optina trial on DME

Ampio Pharmaceuticals, Inc., a biopharmaceutical company developing innovative proprietary drugs for inflammation, eye disease, kidney disease, CNS disease, metabolic disease and male sexual dysfunction and conducting clinical trials on its three lead drugs (Ampion, Optina & Zertane), announced the significant results from their further analysis of its Optina trial on DME.

9 Jul 2012